Cervical Artery Dissection Completed Phase 4 Trials for Phylloquinone (DB01022)

IndicationStatusPhase
DBCOND0032810 (Cervical Artery Dissection)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02046460Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CADTreatment